Clinical utility of probiotics in inflammatory bowel disease

Kelly Dowhower Karpa, Alisha M. Cain

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Many patients with inflammatory bowel disease (IBD) use probiotics to manage this intestinal condition. Despite widespread use of these natural therapies by patients, health care providers may be unfamiliar with probiotics as a treatment modality. This review describes the rationale for use of probiotics in IBD, the history behind current research directions, and recent controlled clinical studies in which efficacy of probiotics has been explored in patients with IBD. Emphasis is placed upon critical analysis of study designs for investigations that used lactic acid-producing bacteria or Saccharomyces boulardii in management of Crohn's disease or ulcerative colitis. While there is suggestion of benefit when patients with ulcerative colitis use bacterial therapies and when patients with Crohn's disease use S boulardii, small sample sizes and methodological flaws in study designs necessitate that additional investigations be conducted before probiotics can be routinely recommended in clinical practice.

Original languageEnglish (US)
Pages (from-to)72-79
Number of pages8
JournalAlternative Therapies in Health and Medicine
Volume17
Issue number1
StatePublished - Jan 1 2011

Fingerprint

Probiotics
Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn Disease
Health Personnel
Sample Size
Lactic Acid
Patient Care
Therapeutics
History
Bacteria
Research

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine

Cite this

@article{dbdfdc4db4024c91b4b016b57e6ea9c7,
title = "Clinical utility of probiotics in inflammatory bowel disease",
abstract = "Many patients with inflammatory bowel disease (IBD) use probiotics to manage this intestinal condition. Despite widespread use of these natural therapies by patients, health care providers may be unfamiliar with probiotics as a treatment modality. This review describes the rationale for use of probiotics in IBD, the history behind current research directions, and recent controlled clinical studies in which efficacy of probiotics has been explored in patients with IBD. Emphasis is placed upon critical analysis of study designs for investigations that used lactic acid-producing bacteria or Saccharomyces boulardii in management of Crohn's disease or ulcerative colitis. While there is suggestion of benefit when patients with ulcerative colitis use bacterial therapies and when patients with Crohn's disease use S boulardii, small sample sizes and methodological flaws in study designs necessitate that additional investigations be conducted before probiotics can be routinely recommended in clinical practice.",
author = "Karpa, {Kelly Dowhower} and Cain, {Alisha M.}",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
volume = "17",
pages = "72--79",
journal = "Alternative Therapies in Health and Medicine",
issn = "1078-6791",
publisher = "InnoVision Communications",
number = "1",

}

Clinical utility of probiotics in inflammatory bowel disease. / Karpa, Kelly Dowhower; Cain, Alisha M.

In: Alternative Therapies in Health and Medicine, Vol. 17, No. 1, 01.01.2011, p. 72-79.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Clinical utility of probiotics in inflammatory bowel disease

AU - Karpa, Kelly Dowhower

AU - Cain, Alisha M.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Many patients with inflammatory bowel disease (IBD) use probiotics to manage this intestinal condition. Despite widespread use of these natural therapies by patients, health care providers may be unfamiliar with probiotics as a treatment modality. This review describes the rationale for use of probiotics in IBD, the history behind current research directions, and recent controlled clinical studies in which efficacy of probiotics has been explored in patients with IBD. Emphasis is placed upon critical analysis of study designs for investigations that used lactic acid-producing bacteria or Saccharomyces boulardii in management of Crohn's disease or ulcerative colitis. While there is suggestion of benefit when patients with ulcerative colitis use bacterial therapies and when patients with Crohn's disease use S boulardii, small sample sizes and methodological flaws in study designs necessitate that additional investigations be conducted before probiotics can be routinely recommended in clinical practice.

AB - Many patients with inflammatory bowel disease (IBD) use probiotics to manage this intestinal condition. Despite widespread use of these natural therapies by patients, health care providers may be unfamiliar with probiotics as a treatment modality. This review describes the rationale for use of probiotics in IBD, the history behind current research directions, and recent controlled clinical studies in which efficacy of probiotics has been explored in patients with IBD. Emphasis is placed upon critical analysis of study designs for investigations that used lactic acid-producing bacteria or Saccharomyces boulardii in management of Crohn's disease or ulcerative colitis. While there is suggestion of benefit when patients with ulcerative colitis use bacterial therapies and when patients with Crohn's disease use S boulardii, small sample sizes and methodological flaws in study designs necessitate that additional investigations be conducted before probiotics can be routinely recommended in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84866629141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866629141&partnerID=8YFLogxK

M3 - Review article

C2 - 21614946

AN - SCOPUS:84866629141

VL - 17

SP - 72

EP - 79

JO - Alternative Therapies in Health and Medicine

JF - Alternative Therapies in Health and Medicine

SN - 1078-6791

IS - 1

ER -